NYAS Conferences
New York Academy of Sciences
left end
Search
divider divider feedback right end
Annals of the New York Academy of Sciences Annals of the New York Academy of Sciences login

Main

Browse Volumes

Forthcoming Volumes

Annals PrePrints

Annals Extra

E-mail Alerts

Subscriptions & Orders

New Proposals

Author Guidelines

About Annals

Help

Get free Annals volume as a NYAS member: http://www.nyas.org/annalsreaderhw
Issue 1058 coverTherapeutic Oligonucleotides: Transcriptional and Translational Strategies for Silencing Gene Expression Volume 1058 published November 2005
Ann. N.Y. Acad. Sci. 1058: 140–150 (2005). doi: 10.1196/annals.1359.022
Copyright © 2005 by the New York Academy of Sciences
description | purchase volume purchase this volume

This Volume
Table of Contents
Description
This Article
Full Text
Full Text (PDF)
Services
Similar articles in this journal
Similar articles in PubMed
Alert me to new issues of the journal
Download to citation manager
Citing Articles
Citing Articles via Google Scholar
Google Scholar
Articles by PANYUTIN, I. V.
Articles by NEUMANN, R. D.
Search for Related Content
PubMed
PubMed Citation
Articles by PANYUTIN, I. V.
Articles by NEUMANN, R. D.
DNA Damage Produced by 125I-Triplex-Forming Oligonucleotides as a Measure of Their Succesful Delivery into Cell Nuclei

IRINA V. PANYUTINa, OLGA A. SEDELNIKOVAb, WILLIAM M. BONNERb, IGOR G. PANYUTINa AND RONALD D. NEUMANNa

aDepartment of Nuclear Medicine, Clinical Center, Bethesda, Maryland 20892, USA
bLaboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA

Address for correspondence: Igor G. Panyutin, Nuclear Medicine Department, NIH, 10 Center Drive, Bethesda, MD 20892-1180. igorp{at}helix.nih.gov

Decay of an Auger-electron-emitting radioisotope can knock out a targeted gene by producing DNA strand breaks within its sequence. For delivery of Auger emitters to genomic targets we used triplex-forming oligonucleotides (TFOs) that bind specifically to their target sequences by forming hydrogen bonds within the major groove of the target duplex. We named this approach antigene radiotherapy. In our previous studies, we demonstrated that 125I-labeled TFOs targeted against the human MDR1 gene produced sequence-specific double strand breaks (DSBs) within this gene in live cultured cells. We also found that conjugation of TFO with nuclear localization signal peptide significantly increased the efficiency of targeting. To screen the wide variety of possible TFO modifications a sensitive and robust assay of DNA damage produced by such 125I-TFOs would be highly desirable. Recently we showed a direct correspondence between the number of decays of 125I incorporated into DNA as 125I-UdR and the number of histone {gamma}-H2AX foci per cell revealed by staining with {gamma}-H2AX antibodies. The technique is 100-fold more sensitive than other DSB-detection methods, thus it is possible to detect as few as an average of 0.5 DSBs per cell in a population of cultured cells. Here we applied this method to evaluate the intracellular DNA damage produced by two 125I-TFOs, the first targeted to the single-copy HPRT gene (125I-TFO-HPRT) and second to a multicopy repeated sequence (GA)n that occurs almost 7000 times in the human genome (125I-TFO-GA). DNA damage produced by 125I-TFO was assessed by staining the cells with {gamma}-H2AX antibody followed by either direct counting {gamma}-H2AX foci or by measuring the {gamma}-H2AX signal using flow cytometry. Both methods produced quantitatively close results; 125I-TFO-GA with multiple nuclear targets produced on average 1.93 times more {gamma}-H2AX foci per cell and generated 1.96 times increase in {gamma}-H2AX antibody staining signal than 125I-TFO-HPRT with a single target. The {gamma}-H2AX-based assay requires considerably less time and effort than the direct measurement of DSB by Southern hybridization applied previously. Therefore, we believe that {gamma}-H2AX-based measurement of DNA damage could be useful for evaluation and cellular DNA accessibility by 125I-labeled DNA targeting agents.

Key Words: targeted radiotherapy • DNA triplex • antigene therapy • Auger emitters






footerLeft footerRight